REMUNITYPRO BY REMODULIN (TREPROSTINIL) INJECTION Trademark

Trademark Overview


On Thursday, June 13, 2024, a trademark application was filed for REMUNITYPRO BY REMODULIN (TREPROSTINIL) INJECTION with the United States Patent and Trademark Office. The USPTO has given the REMUNITYPRO BY REMODULIN (TREPROSTINIL) INJECTION trademark a serial number of 98598862. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 13, 2024. This trademark is owned by United Therapeutics Corporation. The REMUNITYPRO BY REMODULIN (TREPROSTINIL) INJECTION trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery systems
remunitypro by remodulin (treprostinil) injection

General Information


Serial Number98598862
Word MarkREMUNITYPRO BY REMODULIN (TREPROSTINIL) INJECTION
Filing DateThursday, June 13, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the wording RemunityPRO by REMODULIN (treprostinil) Injection to the left of the wording are three overlapping open circles.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDrug delivery systems

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 13, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUnited Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events


Event DateEvent Description
Thursday, June 13, 2024NEW APPLICATION ENTERED